As a result, gaining a better understanding of the mechanisms underlying PD‐L1 aberrant expression in HNSCC will aid in the discovery of potential predictive tumour biomarkers and the overcoming of treatment resistance. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.